Home » Vermillion Rises as Complete Genomics, PacBio See Stocks Falter in March

Vermillion Rises as Complete Genomics, PacBio See Stocks Falter in March

Apr 03, 2012

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion's shares rose 51 percent for the month of March, leading all stocks in the GenomeWeb Daily News Index for the month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Apr 01, 2014

Broader Biotech Space Pulls Down Life Science Tools, MDx Stocks in March

Feb 03, 2009

Helicos, Rosetta Shares Rose Sharply in January

Feb 02, 2015

Foundation Medicine Shares Skyrocket in January as Omics Tools/MDx Stocks Climb 4 Percent

Mar 03, 2014

Myriad Genetics, Vermillion Shares Up Sharply in February

Jan 02, 2015

Veracyte's Shares Rise Sharply in December, but MDx/Omics Tools Stocks Decline Slightly

Dec 03, 2014

Strong Month for NanoString's Stock as GWDN Index Rises

The Scan

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.